Mulder CJJ - Search Results

1

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.

Crouwel F, Simsek M, de Boer MA, Mulder CJJ, van Andel EM, Creemers RH, van Asseldonk DP, van Bodegraven AA, Horjus CS, Visschedijk MC, Weusthuis ALM, Seinen ML, Jharap B, van Schaik FDM, Ahmad I, Boekema PJ, Tack GJ, Wormmeester L, Lutgens MWMD, van Boeckel PGA, Gilissen LPL, Kerkhof M, Russel MGVM, Hoentjen F, Bartelink ME, Kuijvenhoven JP, Maljaars JWJ, van Dop WA, Wonders J, van der Voorn MMPJA, Buiter HJC, de Boer NK. Crouwel F, et al. Among authors: mulder cjj. J Crohns Colitis. 2023 May 3;17(5):738-745. doi: 10.1093/ecco-jcc/jjac183. J Crohns Colitis. 2023. PMID: 36521000 Free PMC article.

2

6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.

Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, Mulder CJ. Derijks LJ, et al. Eur J Gastroenterol Hepatol. 2003 Jan;15(1):63-7. doi: 10.1097/00042737-200301000-00011. Eur J Gastroenterol Hepatol. 2003. PMID: 12544696 Clinical Trial.

3

Microscopic colitis.

Mulder CJ, Harkema IM, Meijer JW, De Boer NK. Mulder CJ, et al. Rom J Gastroenterol. 2004 Jun;13(2):113-7. Rom J Gastroenterol. 2004. PMID: 15229775 Review.

4

Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.

de Boer NK, van Nieuwkerk CM, Aparicio Pages MN, de Boer SY, Derijks LJ, Mulder CJ. de Boer NK, et al. Eur J Gastroenterol Hepatol. 2005 Apr;17(4):457-61. doi: 10.1097/00042737-200504000-00012. Eur J Gastroenterol Hepatol. 2005. PMID: 15756101 Review.

5

6-Thioguanine for Crohn's disease during pregnancy: thiopurine metabolite measurements in both mother and child.

de Boer NK, Van Elburg RM, Wilhelm AJ, Remmink AJ, Van Vugt JM, Mulder CJ, Van Bodegraven AA. de Boer NK, et al. Scand J Gastroenterol. 2005 Nov;40(11):1374-7. doi: 10.1080/00365520510024089. Scand J Gastroenterol. 2005. PMID: 16334449

6

6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?

Derijks LJ, Gilissen LP, de Boer NK, Mulder CJ. Derijks LJ, et al. J Hepatol. 2006 Apr;44(4):821-2. doi: 10.1016/j.jhep.2005.11.049. Epub 2006 Jan 24. J Hepatol. 2006. PMID: 16487623 No abstract available.

7

Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites.

de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. de Boer NK, et al. Am J Gastroenterol. 2006 Jun;101(6):1390-2. doi: 10.1111/j.1572-0241.2006.00538.x. Am J Gastroenterol. 2006. PMID: 16771965

8

Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

van Bodegraven AA, Mulder CJ. van Bodegraven AA, et al. World J Gastroenterol. 2006 Oct 14;12(38):6115-23. doi: 10.3748/wjg.v12.i38.6115. World J Gastroenterol. 2006. PMID: 17036381 Free PMC article. Review.

9

Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.

Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA. Peters JH, et al. Am J Gastroenterol. 2007 Dec;102(12):2814-9. doi: 10.1111/j.1572-0241.2007.01513.x. Am J Gastroenterol. 2007. PMID: 17764491

10

Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism.

de Boer NK, Wong DR, Jharap B, de Graaf P, Hooymans PM, Mulder CJ, Rijmen F, Engels LG, van Bodegraven AA. de Boer NK, et al. Am J Gastroenterol. 2007 Dec;102(12):2747-53. doi: 10.1111/j.1572-0241.2007.01511.x. Epub 2007 Aug 31. Am J Gastroenterol. 2007. PMID: 17764493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page